Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Background. We examined (1) patient characteristics and disease-modifying drug (DMD) exposure in late-onset (LOMS, ≥50 years at symptom onset) versus adult-onset (AOMS, 18–<50 years) MS and (2) the association between interferon-beta (IFNβ) and disability progression in older relapsing-onset MS a...

Full description

Bibliographic Details
Main Authors:	Afsaneh Shirani, Yinshan Zhao, John Petkau, Paul Gustafson, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. van der Kop, Joel Oger, Helen Tremlett
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/451912

Similar Items

The effect of smoking on the symptoms and progression of multiple sclerosis: a review
by: Afsaneh Shirani, et al.
Published: (2010-09-01)

Beta-interferons in multiple sclerosis
by: Aggarwal Sourabh, et al.
Published: (2010-01-01)

Neutralising antibodies to interferon beta in multiple sclerosis
by: Farrell, R. A.
Published: (2010)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
by: Kyla McKay, et al.
Published: (2017-04-01)

Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy
by: Gibbs, Ebrima
Published: (2009)

Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy
by: Gibbs, Ebrima
Published: (2009)

THE INFLUENCE OF NEUTRALIZING ANTIBODIES TO INTERFERON-BETA ON PROGRESSION OF MULTIPLE SCLEROSIS
by: V. Yu. Lizhdvoy, et al.
Published: (2016-07-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01)

A cost-utility analysis of interferon beta for multiple sclerosis.
by: Parkin, et al.
Published: (1998-01-01)

Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
by: S. Jeannin, et al.
Published: (2011-01-01)

Immunopharmacological aspects of methylprednisolone and interferon-beta therapies in multiple sclerosis
by: Boylan, M. T.
Published: (2002)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
by: Elmazny A, et al.
Published: (2020-03-01)

Beta-interferons in multiple sclerosis: A single center experience in India
by: Gupta Salil, et al.
Published: (2010-01-01)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
by: Castrop F, et al.
Published: (2013-09-01)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
by: Cocco E, et al.
Published: (2015-05-01)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
by: De Caro Maria, et al.
Published: (2006-12-01)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01)

Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
by: Ivanović Jovana, et al.
Published: (2019-01-01)

Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
by: E Gibbons, et al.
Published: (2015-01-01)

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
by: Keivan Basiri, et al.
Published: (2012-02-01)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is there an odd one Out?
by: Alexis Clapin
Published: (2012-04-01)

Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
by: Amir Hadi Maghzi, et al.
Published: (2012-02-01)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
by: Naeim Ehtesham, et al.
Published: (2016-11-01)

Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis
by: A.L. Guerrero, et al.
Published: (2011-01-01)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
by: Slobodan M Jankovic
Published: (2010-03-01)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
by: Reuss R
Published: (2013-05-01)

Early stage and long term treatment of multiple sclerosis with interferon-&beta;
by: Angela Applebee, et al.
Published: (2009-05-01)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Damiano Paolicelli, et al.
Published: (2009-07-01)

Erratum to Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE
Published: (2015-01-01)

Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy
by: C. Carbonelli, et al.
Published: (2015-12-01)

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
by: Miraç Ayşen Ünsal
Published: (2019-03-01)

The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis
by: Kowalec, Kaarina
Published: (2016)

Causal inference approaches for dealing with time-dependent confounding in longitudinal studies, with applications to multiple sclerosis research
by: Karim, Mohammad Ehsanul
Published: (2015)

Efficacy and safety of the new drug against multiple sclerosis «PEGylated Interferon beta-1a Human» in monkeys compared with unmodified interferon beta-1a
by: N. A. Spirina, et al.
Published: (2018-02-01)

INTERFERON BETA IN TREATMENT OF DISSEMINATED SCLEROSIS IN ADOLESCENTS — INFLUENCE ON NEUROPSYCHOLOGICAL STATUS AND PAROXYSMAL STATES
by: A.N. Platonova, et al.
Published: (2010-07-01)

THE EFFECTIVENESS OF INTERFERON BETA-1A IN MANAGEMENT OF MULTIPLE SCLEROSIS: A CASE REPORT
by: Journal, Malang
Published: (2020-07-01)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: is there a one odd out?
by: Alexis Clapin
Published: (2012-09-01)

Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis
by: Éric Toussirot, et al.
Published: (2014-01-01)

INTERFERON BETA IN TREATMENT OF DISSEMINATED SCLEROSIS IN ADOLESCENTS — INFLUENCE ON NEUROPSYCHOLOGICAL STATUS AND PAROXYSMAL STATES
by: A.N. Platonova, et al.
Published: (2010-01-01)

INTERFERON BETA 1B FOR THE IMMUNOMODULATORY TREATMENT OF MULTIOCULAR SCLEROSIS IN PEDIATRIC NEUROLOGIC PRACTICES
by: O.V. Bykova, et al.
Published: (2006-12-01)

Cannot write session to /tmp/vufind_sessions/sess_gcv1lmbo46sha7ifktdd2u4jl9